CAS No.:59-30-3

TOXICITY DATA with REFERENCE：

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
guinea pig	LD50	intravenous	120mg/kg (120mg/kg)		Drugs in Japan Vol. -, Pg. 1409, 1995.
mouse	LD50	intraperitoneal	85mg/kg (85mg/kg)	BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: MUSCLE WEAKNESS BEHAVIORAL: COMA	Experientia. Vol. 41, Pg. 72, 1985.
mouse	LD50	intravenous	282mg/kg (282mg/kg)		Toxicology and Applied Pharmacology. Vol. 23, Pg. 537, 1972.
mouse	LD50	oral	10gm/kg (10000mg/kg)		Toxicology and Applied Pharmacology. Vol. 23, Pg. 537, 1972.
mouse	LDLo	subcutaneous	200mg/kg (200mg/kg)	KIDNEY, URETER, AND BLADDER: OTHER CHANGES BLOOD: CHANGES IN SPLEEN	Proceedings of the Society for Experimental Biology and Medicine. Vol. 71, Pg. 544, 1949.
rabbit	LD50	intravenous	410mg/kg (410mg/kg)		Drugs in Japan Vol. -, Pg. 1409, 1995.
rat	LD50	intravenous	500mg/kg (500mg/kg)		Drugs in Japan Vol. -, Pg. 1409, 1995.

Consensus Reports：

 

SAFETY PROFILE：

Risk Statements: 33-62-68
R33: Danger of cumulative effects. 
R62: Risk of impaired fertility. 
R68: Possible risk of irreversible effects.
Safety Statements: 24/25
S24/25: Avoid contact with skin and eyes.
WGK Germany: 1
RTECS: LP5425000
F: 8

Standards and Recommendations：

 

Analytical Methods：